Profiel
Yi Hong Yao is currently Chief Scientific Officer at AbelZeta Pharma, Inc. since 2015.
Formerly, Dr. Yao was Director at MedImmune LLC from 2011 to 2015.
Education includes graduate studies at Boston University, a doctorate from the University of Kansas, and undergraduate studies at Fudan University.
Actieve functies van Yi Hong Yao
| Bedrijven | Functie | Begin |
|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2015 |
Eerdere bekende functies van Yi Hong Yao
| Bedrijven | Functie | Einde |
|---|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Bestuurslid | 01-07-2015 |
Opleiding van Yi Hong Yao
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbelZeta Pharma, Inc.
AbelZeta Pharma, Inc. BiotechnologyHealth Technology Develops cell therapies to cure cancer and inflammatory & immunological diseases | Health Technology |
















